2026 Symposia

Join us for the 2026 Health Law & Policy Brief Symposium, where experts will explore how artificial intelligence is transforming drug development and the legal frameworks guiding it. The panel will delve into the legal, ethical, and policy challenges shaping this rapidly evolving field. Following the discussion, guests are invited to enjoy a reception.

The symposium will take place on Wednesday, March 4, 2026, on the American University Washington College of Law campus in Washington, DC. The agenda for the afternoon is as follows:

  • 3:00–3:30 PM: Arrival and networking
  • 3:30–5:00 PM: Moderated panel discussion
  • 5:00–6:00 PM: Reception

Moderator
Lewis Grossman, Professor of Law, American University Washington College of Law

Panelists
Vanessa Burrows, attorney at Simpson Thacher based in Washington, DC, advising clients on FDA regulatory matters and healthcare compliance.

Anjali Deshmukh, Assistant Professor of Law at Seton Hall Law, whose research focuses on pharmaceutical regulation and emerging technologies, including AI.

Elaine Lippmann, Principal at Leavitt Partners in Washington, DC, with extensive experience in FDA leadership and pharmaceutical regulatory policy.

Nicole Mahoney, Executive Director for Regulatory Policy at Novartis and global lead for data and digital technologies, including real-world evidence and artificial intelligence.

The Symposium will be held in Ceremonial Classroom NT01 and virtually over Zoom. 

Register Here